Allianz Asset Management Gmb H Protagonist Therapeutics, Inc Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 19,300 shares of PTGX stock, worth $783,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,300

Previous 11,100 73.87%

Holding current value

$783,580

Previous $384,000 125.78%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$33.72 - $47.33 $276,504 - $388,106	8,200 Added 73.87%	19,300 $867,000
Q1 2024 May 13, 2024	BUY	$21.79 - $32.15 $241,869 - $356,865	11,100 New	11,100 $321,000
Q4 2022 Feb 13, 2023	BUY	$7.36 - $11.17 $158,240 - $240,155	21,500 New	21,500 $234,000
Q2 2022 Aug 12, 2022	BUY	$7.06 - $25.52 $221,267 - $799,822	31,341 Added 23.61%	164,075 $1.3 Million
Q1 2022 May 13, 2022	SELL	$23.34 - $36.08 $48,057 - $74,288	-2,059 Reduced 1.53%	132,734 $3.14 Million
Q4 2021 Feb 11, 2022	BUY	$17.63 - $37.1 $1.51 Million - $3.18 Million	85,622 Added 174.13%	134,793 $4.61 Million
Q3 2021 Nov 10, 2021	SELL	$12.95 - $49.69 $324,902 - $1.25 Million	-25,089 Reduced 33.79%	49,171 $871,000
Q3 2020 Nov 13, 2020	SELL	$15.19 - $22.4 $23,240 - $34,272	-1,530 Reduced 2.02%	74,260 $1.45 Million
Q2 2020 Aug 14, 2020	SELL	$6.19 - $18.84 $162,846 - $495,642	-26,308 Reduced 25.77%	75,790 $1.34 Million
Q1 2020 May 14, 2020	BUY	$5.4 - $9.22 $162,523 - $277,494	30,097 Added 41.8%	102,098 $720,000
Q4 2019 Feb 13, 2020	SELL	$4.69 - $13.45 $193,579 - $555,148	-41,275 Reduced 36.44%	72,001 $507,000
Q3 2019 Nov 13, 2019	SELL	$9.41 - $16.56 $101,759 - $179,079	-10,814 Reduced 8.71%	113,276 $1.39 Million
Q2 2019 Aug 08, 2019	BUY	$8.98 - $12.96 $423,631 - $611,388	47,175 Added 61.33%	124,090 $1.5 Million
Q1 2019 May 13, 2019	BUY	$6.5 - $13.77 $499,947 - $1.06 Million	76,915 New	76,915 $967,000

Others Institutions Holding PTGX

# of Institutions

248

Shares Held

56.7M

Call Options Held

76.3K

Put Options Held

114K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.99B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Protagonist Therapeutics, Inc Transaction History